ClearBridge Investments’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-542,966
Closed -$37.2M 711
2024
Q4
$37.2M Buy
542,966
+46,582
+9% +$3.25M 0.03% 356
2024
Q3
$35.7M Buy
496,384
+74,919
+18% +$5.29M 0.03% 375
2024
Q2
$29.2M Buy
421,465
+80,025
+23% +$5.84M 0.02% 404
2024
Q1
$27.3M Buy
+341,440
New +$30.4M 0.02% 418

Other funds holding CNMD

ClearBridge Investments's CNMD Position: Q1 2025 in Review

ClearBridge Investments sold out of CONMED (CNMD) in Q1 2025, closing a stake of 542,966 shares — an estimated $37.2M sold.

ClearBridge Investments first reported a position in CNMD in Q1 2024 and held it in 4 quarters. The position peaked at $37.2M in Q4 2024. 280 funds tracked by Wall St. Rank hold CNMD as of Q1 2025.

  • ClearBridge Investments reported no remaining CONMED position as of Q1 2025 after selling out during the quarter.
  • ClearBridge Investments sold 542,966 CONMED shares in Q1 2025, an estimated $37.2M.
  • ClearBridge Investments first reported a position in CONMED in Q1 2024 and held it in 4 quarters.
  • ClearBridge Investments's CONMED position peaked at $37.2M in Q4 2024.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q1 2025.

Based on ClearBridge Investments's 13F filing for Q1 2025, filed 13 May 2025.